Page 35 - 《中国药房》2024年4期
P. 35

川芎挥发油对雷公藤甲素体外透皮性能及细胞毒性的影响
                                                                                                   Δ


                 1*
                          1
                                                   2
                                                                           3
                                                                                    1 #
                                                           1
                                                                   1
          蒋 成 ,臧振中 ,陈丽华 ,朱海婷 ,傅世华 ,朱卫丰 ,吴文婷 ,施 韡 ,管咏梅 (1.江西中医药大学现代中
                                           2
                                  1
          药制剂教育部重点实验室,南昌 330004;2.江西中医药大学药学院,南昌 330004;3.福建中医药大学附属康
          复医院药学部,福州 350003)
          中图分类号  R965      文献标志码  A      文章编号  1001-0408(2024)04-0413-06
          DOI  10.6039/j.issn.1001-0408.2024.04.06
          摘  要  目的  探究川芎挥发油对雷公藤甲素体外透皮性能和细胞毒性的影响。方法  采用气相色谱-质谱联用法对川芎挥发油
          的化学成分进行分析。分离KM小鼠下腹皮肤,分为雷公藤甲素、雷公藤甲素配伍川芎挥发油1∶10、1∶50、1∶100组(以下简称“配伍
          1∶10”“配伍1∶50”“配伍1∶100”组),将各组小鼠皮肤与相应乳膏各0.2 g充分接触24 h后,采用高效液相色谱法测定各组接收液中
          雷公藤甲素的累计透皮量(Qn ),并计算透皮吸收速率(Jss );再以人永生化角质形成细胞(HaCat)为模型,采用CCK-8法检测不同浓
          度川芎挥发油和雷公藤甲素配伍前后的细胞存活率。结果  共鉴定出62个川芎挥发油化学成分,包括Z-藁本内酯、洋川芎内酯、β-
          瑟林烯等。与雷公藤甲素组比较,配伍1∶10组和配伍1∶50组24 h内雷公藤甲素的Qn (P<0.01)和Jss有所升高,而配伍1∶100组的Qn
         (P<0.05)和Jss有所下降。与雷公藤甲素组比较,雷公藤甲素浓度在36、72、144 ng/mL时,配伍1∶10组和配伍1∶50组可以显著提高
          HaCat细胞的存活率(P<0.05或P<0.01),而配伍1∶100组细胞的存活率反而降低,但差异无统计学意义(P>0.05)。结论  雷公藤
          甲素与川芎挥发油在配伍比例为1∶10和1∶50时可以促进雷公藤甲素的透皮吸收,且可降低雷公藤甲素对HaCat细胞的毒性。
          关键词  川芎挥发油;雷公藤甲素;透皮吸收;配伍;增效减毒;细胞毒性

          Effect  of  volatile  oil  of  Ligusticum  chuanxiong  on  transdermal  properties  and  cytotoxicity  of  triptolide  in
          vitro
                                                                                           1
                                                                             2
                                                                                                        1
                                                                  2
                                                     1
                      1
                                        1
          JIANG Cheng ,ZANG Zhenzhong ,CHEN Lihua ,ZHU Haiting ,FU Shihua ,ZHU Weifeng ,WU Wenting ,SHI
          Wei ,GUAN Yongmei(1.  Key  Laboratory  of  Modern  Preparation  of Traditional  Chinese  Medicine,  Ministry  of
             3
                             3
          Education,  Jiangxi  University  of  Traditional  Chinese  Medicine,  Nanchang  330004,  Jiangxi;2.  School  of
          Pharmacy,  Jiangxi  University  of  Traditional  Chinese  Medicine,  Nanchang  330004,  Jiangxi;3.  Dept.  of  Pharmacy,
          Rehabilitation Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou 350003)
          ABSTRACT   OBJECTIVE  To  explore  the  effect  of  volatile  oil  of  Ligusticum  chuanxiong  on  the  transdermal  properties  and
          cytotoxicity  of  triptolide  in  vitro.  METHODS  The  chemical  constituents  of  the  volatile  oil  of  L.  chuanxiong  were  analyzed  by  gas
          chromatography-mass  spectrometry.  The  lower  abdominal  skin  of  KM  mice  was  separated  and  divided  into  triptolide  group,
          triptolide  in  compatibility  with  volatile  oil  of  L.  chuanxiong  groups  at  1∶10,  1∶50,  1∶100 (hereinafter  referred  to  as
         “compatibility 1∶10”“compatibility 1∶50”“compatibility 1∶100” groups). After the skin of mice in each group was fully exposed to
          0.2  g  of  the  corresponding  cream  for  24  h,  the  cumulative  transdermal  dose (Qn )  of  triptolide  in  the  receiving  solution  of  each
          group was determined by high-performance liquid chromatography, and the transdermal absorption rate (Jss ) was calculated. Human
          immortalized keratinocytes (HaCat) were used as a model, the CCK-8 method was used to detect the cell survival rate of different
          concentrations  of  the  volatile  oil  of  L.  chuanxiong  and  triptolide  before  and  after  compatibility.  RESULTS  A  total  of  62  chemical
          constituents of the volatile oil of L. chuanxiong were identified, including Z-ligustilide, senkyunolide, and β-selinene. The Qn (P<
          0.01)  and  Jss  of  triptolide  increased  within  24  h  in  the  compatibility  1∶10  and  1∶50  groups,  while  the  Qn (P<0.05)  and  Jss
          decreased  in  the  compatibility  1∶100  group  as  compared  with  the  triptolide  group.  Compared  with  the  triptolide  group,  the  cell
          survival rate of HaCat was significantly increased in the compatibility 1∶10 and 1∶50 groups when the triptolide concentrations were
          36,  72  and  144  ng/mL (P<0.05  or  P<0.01);  while  the  cell  survival  rate  of  HaCat  was  decreased  in  the  compatibility  1∶100
          group,  but  the  difference  was  not  statistically  significant (P>0.05).  CONCLUSIONS  When  the  compatibility  ratio  of  triptolide
                                                             and  volatile  oil  of  L.  chuanxiong  was  1∶10  or  1∶50,  it  can
             Δ  基金项目 国 家 自 然 科 学 基 金 地 区 科 学 基 金 项 目(No.
                                                             promote the transdermal absorption of triptolide and reduce the
          82060722);江西中医药大学校级研究生创新专项(No.JZYC22S69);
                                                             cytotoxicity of triptolide to HaCat.
          福建中医药大学校管课题临床专项(No.XB2021049)                      KEYWORDS
             *第一作者 硕士研究生。研究方向:中药配伍减毒及制剂开发。                                volatile   oil   of   Ligusticum   chuanxiong;
          E-mail:2310240230@qq.com                           triptolide;  transdermal  absorption;  compatibility;  synergism
             # 通信作者 教授,博士生导师,博士。研究方向:中药新制剂与新                 and attenuation; cytotoxicity
          技术。电话:0791-87118658。E-mail:guanym2008@163.com


          中国药房  2024年第35卷第4期                                                 China Pharmacy  2024 Vol. 35  No. 4    · 413 ·
   30   31   32   33   34   35   36   37   38   39   40